Summary
Inherited susceptibility to breast cancer is associated with an early onset and bilateral disease. The extent of familial risks has not, however, been fully assessed in population-based incidence studies. The purpose of the study was to quantify the risks for cancers of the breast, ovary and other sites of close relatives of women in whom breast cancer was diagnosed at an early age. Records collected between 1943 and 1990 at the Danish Cancer Registry were searched, and 2860 women were found in whom breast cancer was diagnosed before age 40. Population registers and parish records were used to identify 14 973 parents, siblings and offspring of these women. Cancer occurrence through to 31 December 1993 was determined within the Cancer Registry’s files and compared with national incidence rates. Women with early-onset breast cancer were at a nearly fourfold increased risk of developing a new cancer later in life (268 observed vs 68.9 expected). The excess risk was most evident for second cancer of the breast (181 vs 24.5) and for ovarian cancer (20 vs 3.3). For mothers and sisters, risks for cancers of the breast and ovary were significantly increased by two- to threefold. Bilateral breast cancer and breast–ovarian cancer were very strong predictors of familial risks, with one in four female relatives predicted to develop breast and/or ovarian cancer by age 75. Mothers had a slightly increased risk of colon cancer, but not endometrial cancer. The risk for breast cancer was also increased among fathers (standardized incidence ratio 2.5; 95% CI 0.5–7.4) and especially brothers (29; 7.7–74), although based on small numbers. The risk for prostatic cancer was unremarkable. In this large population-based survey, the first-degree relatives of women who developed breast cancer before age 40 were prone to ovarian cancer as well as male and female breast cancer, but not other tumours that may share susceptibility genes with breast cancer.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Amos, C. I. & Struewing, J. P. (1993). Genetic epidemiology of epithelial ovarian cancer. Cancer 71: (suppl.2) 566–572.
Anderson, D. E. & Badzioch, M. D. (1993). Familial breast cancer risks: effects of prostate and other cancers. Cancer 72: 114–119.
Anderson, K. E., Easton, D. F., Matthews, F. E. & Peto, J. (1992). Cancer mortality in the first degree relatives of young breast cancer patients. Br J Cancer 66: 599–602.
Bebb, G., Glickman, B., Gelman, K. & Gatti, R. (1997). ‘At risk’ for breast cancer (commentary). Lancet 349: 1784–1785.
Boice Jr, J. D., Harvey, E., Blettner, M., Stovall, M. & Flannery, J. T. (1992). Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326: 781–785.
Claus, E. B., Risch, N. J. & Thompson, W. D. (1990). Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131: 961–972.
Claus, E. B., Risch, N. J. & Thompson, W. D. (1991). Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48: 232–242.
Crook, T., Crossland, S., Crompton, M. R., Osin, P. & Gusterson, B. A. (1997). p53 mutations in BRCA1-associated familial breast cancer. Lancet 350: 638–639.
Danish Board of Health (1997). Cancer incidence in Denmark 1994. In Health Statistics, vol. 7 Danish Board of Health: Copenhagen
Eby, N., Chang-Claude, J. & Bishop, D. T. (1994). Familial risk and genetic susceptibility for breast cancer. Cancer Causes Control 4: 458–470.
FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O’Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., Sgroi, D. C., Smith, B. L., Younger, J. W., Garber, J. E., Duda, R. B., Mayzel, K. A., Isselbacher, K. J., Friend, S. H. & Haber, D. A. (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334: 143–149.
FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J. & Haber, D. A. (1997). Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet 15: 307–310.
Ford, D., Easton, D. F. & Peto, J. (1995). Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457–1462.
Garber, J. E., Goldstein, A. M., Kantor, A. F., Dreyfus, M. G., Fraumeni, J. F. & Li, F. P. (1991). Follow-up study of twenty-four families with Li–Fraumeni syndrome. Cancer Res 51: 6094–6097.
Goldgar, D. E., Easton, D. F., Cannon-Albright, L. A. & Skolnick, M. H. (1994). Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600–1608.
Gudmundsson, J., Johannesdottir, G., Arason, A., Bergthorsson, J. T., Ingvarsson, S., Egilsson, V. & Barkardottir, R. B. (1996). Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 58: 749–756.
Inskip, P. D., Stovall, M. & Flannery, J. T. (1994). Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 86: 983–988.
Krainer, M., Silva-Arrieta, S., FitzGerald, M. G., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D. J., Unsal, H., Finkelstein, D. M., Bowcock, A., Isselbacher, K. J. & Haber, D. A. (1997). Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med 336: 1416–1421.
Langston, A. A., Malone, K. E., Thompson, J. D., Daling, J. R. & Ostrander, E. A. (1996). BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334: 137–142.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M. G., Tucker, M. A. & Miller, R. W. (1988). A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358–5362.
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. & Parsons, R. (1997). PTEN a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–1947.
Malone, K. E., Daling, J. R., Thompson, J. D., O’Brien, C. A., Francisco, L. V. & Ostrander, E. A. (1998). BRCA1 mutations and breast cancer in the general population. JAMA 279: 922–929.
Negri, E., Braga, C., Vecchia, C. L., Franceschi, S. & Parazzini, F. (1997). Family history of cancer and risk of breast cancer. Int J Cancer 72: 735–738.
Newman, B., Millikan, R. C. & King, M-C (1997). Genetic epidemiology of breast and ovarian cancers. Epidemiol Rev 19: 69–79.
Olsen, J. H., Boice, J. D., Seersholm, N., Bautz, A. & Fraumeni, J. F. (1995). Cancer in parents of children with cancer. N Engl J Med 333: 1594–1599.
Peto, J., Easton, D. F., Matthews, F. E., Ford, D. & Swerdlow, A. J. (1996). Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 65: 275–283.
Pharoah, P. D., Day, N. E., Duffy, S., Easton, D. F. & Ponder, B. A. (1997). Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71: 800–809.
Rebbeck, T. R., Couch, K. J., Kant, J., Calzone, K., DeShano, M., Peng, Y., Chen, K., Garber, J. E. & Weber, B. L. (1996). Genetic heterogenicity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 59: 547–553.
Rothman, K. J. & Boice, J. D. (1979). Epidemiologic Analysis with a Programmable Calculator, DHHS publication no. (NIH) 79-1649. Government Printing Office: Washington, DC
Schildkraut, J. M., Risch, N. & Thompson, W. D. (1989). Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet 45: 521–529.
Sellers, T. A., Potter, J. D., Rich, S. S., Drinkard, C. R., Bostick, R. M., Kushi, L. H., Zheng, W. & Folsom, A. R. (1994). Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 86: 1860–1865.
Slattery, M. L. & Kerber, R. A. (1993). A comprehensive evaluation of family history and breast cancer risk: the Utah Population Database. J Am Med Assoc 270: 1563–1568.
Storm, H. H., Andersson, M., Boice, J. D., Blettner, M., Stovall, M., Mouridsen, H. T., Dombernowsky, P., Roce, C., Jacobsen, A. & Pedersen, M. (1992). Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84: 1245–1250.
Stratton, M. R. & Wooster, R. (1996). Hereditary predisposition to breast cancer. Curr Opinions Genet Dev 6: 93–97.
Struewing, J. P., Tarone, R. E., Li, F., Brody, L. C. & Boice, J. D. (1996). BRCA1 mutations in young women with breast cancer (letter). Lancet 347: 1493
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C. & Tucker, M. A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401–1408.
Teare, M. D., Wallace, S. A., Harris, M., Howell, A. & Birch, J. M. (1994). Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer 70: 102–111.
Tulinius, H., Egilsson, V. & Olafsdottir, G. H., Sigvaldson (1992a). Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Br Med J 305: 855–857.
Tulinius, H., Sigvaldsson, H., Olafsdottir, G. & Tryggvadottir, L. (1992b). Epidemiology of breast cancer in families in Iceland. J Med Genet 29: 158–164.
Tulinius, H., Olafsdottir, G. H., Sigvaldason, H., Tryggvadottir, L. & Bjarnadottir, K. (1994). Neoplastic diseases in families of breast cancer patients. J Med Genet 31: 618–621.
Varley, J. M., Evans, D. G. & Birch, J. M. (1997). Li–Fraumeni syndrome – a molecular and clinical review. Br J Cancer 76: 1–14.
Whittemore, A. S., Gong, G. & Itnyre, J. (1997). Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case–control studies of ovarian cancer. Am J Hum Genet 60: 496–504.
World Health Organization (1957). Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 7th rev. World Health Organization: Geneva
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Olsen, J., Seersholm, N., Boice, J. et al. Cancer risk in close relatives of women with early-onset breast cancer – a population-based incidence study. Br J Cancer 79, 673–679 (1999). https://doi.org/10.1038/sj.bjc.6690106
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690106
Keywords
This article is cited by
-
A constant risk for familial breast cancer? A population-based family study
Breast Cancer Research (2009)
-
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
British Journal of Cancer (2009)
-
Heritable breast cancer in twins
British Journal of Cancer (2002)
-
High constant incidence in twins and other relatives of women with breast cancer
Nature Genetics (2000)